Psychedelic-assisted psychotherapy aims to heal conditions such as depression, PTSD, addiction, anorexia nervosa, and end-of-life existential anxiety rather than merely treat symptoms. The paper outlines multi-level effects from molecular to phenomenological levels, describing how psychedelics influence gene expression, receptor molecules, neural networks, and brain plasticity. This approach helps patients re-orient themselves relative to their world, leading to symptom reduction or disappearance.
Psychedelic-assisted psychotherapy, using substances like MDMA and psilocybin, has shown high effectiveness for conditions such as PTSD, addiction, and depression, often healing patients where conventional pharmaceuticals fail. Unlike biological drug treatments or traditional talk therapies, these therapies do not rely on chronic brain chemistry alteration or extended therapeutic models. Using philosophical methods, the paper argues that objections to psychedelics in psychotherapy are unwarranted, and that the healing they foster is well-suited to address the competitive, isolating, and alienating nature of modern society.